Table 1.
Sample characteristics, by gender
| Men n=203 |
Women n=72 |
|
|---|---|---|
| Centre: n (%) | ||
| East & North East London | 68 (33.5) | 29 (40.3) |
| South London | 50 (24.6) | 14 (19.4) |
| Manchester | 34 (16.8) | 12 (16.7) |
| Liverpool | 51 (25.1) | 17 (23.6) |
| Age: mean (SD) | 42.07 (10.72) | 42.51 (10.40) |
| Duration of illness: median (IQR) | 10 (7 – 17) | 12 (7 – 20) |
| Number of hospitalisations: median (IQR) | 3 (1 – 5) | 3.5 (1.5 – 7) |
| Live alone: n (%) | 146 (71.9%) | 34 (47.2%) |
| Have at least one child: n (%) | 53 (26.4%) | 36 (50.7%) |
| PANSS total score: mean (SD) | ||
| Negative subscale | 23.34 (4.50) | 22.62 (3.81) |
| Positive subscale | 13.89 (4.90) | 14.54 (5.02) |
| General subscale | 33.41 (8.45) | 35.56 (8.08) |
| CAINS total score: mean (SD) | ||
| CAINS Expressive subscale | 2.42 (0.63) | 2.43 (0.58) |
| CAINS Experiential subscale | 2.00 (0.89) | 1.79 (1.02) |
| Calgary Depression Scale: mean (SD) | 4.47 (4.15) | 5.32 (4.89) |
| Antipsychotic Dose (DDD): mean (SD) | 1.65 (1.28) | 1.45 (0.97) |
SD, standard deviation; IQR, Inter-quartile range; PANSS, Positive and Negative Syndrome Scale; CAINS, Clinical Assessment Interview for Negative Symptoms; DDD, Defined Daily Dose.